In a regulatory filing, BioCryst (BCRX) disclosed that on February 28, Anthony Doyle, the CFO of the company, notified it of his intention to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback